rs866975469
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001134363.3(RBM20):c.3076G>A(p.Glu1026Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,551,664 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.3076G>A | p.Glu1026Lys | missense_variant | Exon 11 of 14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.2911G>A | p.Glu971Lys | missense_variant | Exon 11 of 14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.2692G>A | p.Glu898Lys | missense_variant | Exon 11 of 14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.2692G>A | p.Glu898Lys | missense_variant | Exon 11 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000383 AC: 6AN: 156724Hom.: 0 AF XY: 0.0000361 AC XY: 3AN XY: 83020
GnomAD4 exome AF: 0.0000200 AC: 28AN: 1399448Hom.: 1 Cov.: 33 AF XY: 0.0000261 AC XY: 18AN XY: 690224
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74368
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:2
- -
- -
Cardiovascular phenotype Uncertain:1
The p.E1026K variant (also known as c.3076G>A), located in coding exon 11 of the RBM20 gene, results from a G to A substitution at nucleotide position 3076. The glutamic acid at codon 1026 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and lysine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Dilated cardiomyopathy 1DD Benign:1
- -
Primary dilated cardiomyopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at